Nestlé 雀巢
Oral Impact® 速癒素™ 減糖即飲裝 癌症治療專用營養品 (250毫升) - 全港格價
Oral Impact® 速癒素™ 減糖即飲裝 癌症治療專用營養品 (250毫升) - 全港格價
無法載入取貨服務供應情況
保存方法
存放於攝氏25度以下陰涼乾爽處。
產品用途
獲歐洲營養學會(ESPEN)推薦三大免疫營養１，
配方特別含有精氨酸(Arginine)、核苷酸(Nucleotides)
及奧美加3魚油 (Omega 3 fish oil)。
醫學臨床研究證明 , 有助：
• 提升白血球指數2
• 避免療程延誤
• 紓緩癌症治療副作用3
• 增加體重
• 減少疲勞4
最受腫瘤科醫護推薦*
全港銷量No.1#
減糖82%+, 更適合關注血糖人士^
References:
1. Muscaritoli M et al. Clinical Nutrition 2021;40:2898-2913
2. Maruyama T et al. Nutrition 2011;27:146-152
3. 改善頭頸癌病人在放化療期間所出現的一些治療副作用。Machon C, et al. Support Care Cancer 2012;20:3129–3135.
4. 速癒素TM營養品含鐵及維他命B(B2及B12), 有助減少疲勞
*速癒素TM品牌為最多受訪腫瘤科醫護人員推薦的癌症治療專用營養品- 根據香港尼爾森市場調查公司於2019年4-5月之調查。調查對象為香港私家腫瘤科醫護人員。樣本數目為15.（©尼爾森公司版權所有）
#銷售額及銷售量數據根據尼爾森公司2013年8月-2023年7月於全港超市、藥房及便利店癌症/化療/電療 類別專用營養品零售調查報告(©尼爾森公司版權所有)
+速癒素TM減糖配方（即飲裝）每100毫升含2克糖比原配方(即飲裝)每100毫升含11.1克糖少82%糖。
^此產品沒有根據《藥劑業及毒藥條例》或《中醫藥條例》註冊。為此產品作出的任何聲稱亦沒有為進行該等註冊而接受評核。 此產品並不供作診斷、治療或預防任何疾病之用。
產品使用方法
確診患癌後
每天2次 ,每次1支
每次治療※前5天
每天3次 ,每次1支
治療※期間及治療※後
每天2次 ,每次1支
※治療包括電療、化療、手術、標靶治療及免疫治療
特殊醫用食品
請遵照醫護人員指示下使用
Storage Condition
Store in cool and dry place where below 25℃.
Product Indication
Immunonutrition, including Arginine, Nucleotides, and Omega 3 fish oil, is recommended by the European Society of Nutrition (ESPEN) １. Clinical studies have proven that it helps in the following ways:
• Improving white blood cell level2
• Avoiding delays in treatment
• Alleviating the side effects of cancer treatment3
• Promoting weight gain.
• Reduce fatigue4
Top recommended by oncology healthcare professionals. *
Bestselling in Hong Kong, ranked No. 1 in sales. #
Reduced sugar 82%+ .This product is suitable for people concerned about blood sugar. ^
References:
1. Muscaritoli M et al. Clinical Nutrition 2021;40:2898-2913
2. Maruyama T et al. Nutrition 2011;27:146-152
3. Improving the treatment-related side effects experienced by patients with head and neck cancer during radiation and chemotherapy. Machon C, et al. Support Care Cancer 2012;20:3129–3135.
4. ORAL IMPACTTM nutritional supplement contains Iron and Vitamin B (B2 and B12) which support the reduction of fatigue
*ORAL IMPACTTM the brand most recommended by oncology healthcare professionals for cancer specific formula - according to a survey conducted by Nielsen in Hong Kong from April to May 2019, the respondents were private oncology healthcare professionals in Hong Kong. The sample size was 15. (©️ Copyright by Nielsen)
#Sales revenue and sales volume data are based on Nielsen's retail survey report on specialized nutritional products in the cancer/chemotherapy/radiotherapy category from August 2013 to July 2023 in supermarkets, pharmacies, and convenience stores across Hong Kong. (©️ Copyright by Nielsen)
+Oral Impact Reduced Sugar Formula (ready-to-drink) contains 2 g sugar per 100 mL, which is 82% less sugar compared to the original formula (ready-to-drink) which contains 11.1 g sugar per 100 mL.
^This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subjected to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.
Product Usage
After cancer diagnosis
2 times per day, 1 bottle per time
5 days before every treatment※
3 times per day, 1 bottle per time
During treatment※ and after treatment^
2 times per day, 1 bottle per time
※Treatment includes radiotherapy, chemotherapy, targeted therapy and immunotherapy.
Food for special medical purposes
Use Under Medical Supervision
